| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1998PNAS...95.3100J |
| P356 | DOI | 10.1073/PNAS.95.6.3100 |
| P932 | PMC publication ID | 19701 |
| P698 | PubMed publication ID | 9501222 |
| P5875 | ResearchGate publication ID | 51298937 |
| P2093 | author name string | C. D. Funk | |
| L. F. Brass | |||
| E. N. Johnson | |||
| P2860 | cites work | Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase | Q24295267 |
| Cloning of the cDNA for human 12-lipoxygenase | Q24299952 | ||
| Purification and characterization of recombinant histidine-tagged human platelet 12-lipoxygenase expressed in a baculovirus/insect cell system | Q24308744 | ||
| Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor | Q24323906 | ||
| Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets | Q24564188 | ||
| 12-HETE inhibits the binding of PGH2/TxA2 receptor ligands in human platelets | Q28274475 | ||
| The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C | Q28327651 | ||
| Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein | Q28505058 | ||
| Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene | Q28512170 | ||
| Functional expression and cellular localization of a mouse epidermal lipoxygenase | Q28513319 | ||
| Immunocytochemical localization of platelet-type arachidonate 12-lipoxygenase in mouse blood cells | Q28593560 | ||
| cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases | Q28594638 | ||
| The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. | Q30448825 | ||
| Native and mutant 5-lipoxygenase expression in a baculovirus/insect cell system | Q33849757 | ||
| Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins | Q33902134 | ||
| Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia | Q34430043 | ||
| Mammalian lipoxygenases: molecular structures and functions | Q35460975 | ||
| Prostaglandins and thromboxanes | Q37802829 | ||
| Factors responsible for ADP-induced release reaction of human platelets | Q39340022 | ||
| Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase | Q39692740 | ||
| A review of possible roles of the platelet 12-lipoxygenase | Q39860140 | ||
| Occurrence of lipoxygenase products in membranes of rabbit reticulocytes. Evidence for a role of the reticulocyte lipoxygenase in the maturation of red cells | Q41193209 | ||
| The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice | Q41245074 | ||
| Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase | Q41643855 | ||
| Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation | Q44988917 | ||
| Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. | Q52512619 | ||
| Role of the thrombin receptor in development and evidence for a second receptor. | Q52519548 | ||
| Sandy: a new mouse model for platelet storage pool deficiency | Q68038207 | ||
| 12 -Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation | Q68251774 | ||
| Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes | Q70061806 | ||
| Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats | Q71494164 | ||
| Deficiency of platelet lipoxygenase activity in myeloproliferative disorders | Q71586555 | ||
| Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol | Q71690422 | ||
| In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice | Q72600793 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Arachidonate 12-lipoxygenase | Q21494714 |
| P304 | page(s) | 3100–3105 | |
| P577 | publication date | 1998-03-17 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase | |
| P478 | volume | 95 |
| Q41917191 | 12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition. |
| Q50893125 | 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. |
| Q34207687 | 12-lipoxygenase: a potential target for novel anti-platelet therapeutics |
| Q92423510 | 12/15 Lipoxygenase as a Therapeutic Target in Brain Disorders |
| Q36777936 | A guide to murine platelet structure, function, assays, and genetic alterations. |
| Q92955441 | ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway |
| Q34796480 | ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMP |
| Q27014988 | Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs |
| Q47308552 | An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury |
| Q77360947 | Anandamide activates human platelets through a pathway independent of the arachidonate cascade |
| Q35550212 | Antiplatelet therapy: in search of the 'magic bullet'. |
| Q34159100 | Arachidonate 12-lipoxygenases |
| Q92257954 | Arachidonic Acid Metabolism and Kidney Inflammation |
| Q28252674 | Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid |
| Q24531388 | Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. |
| Q48157381 | Dietary modulation of oxylipins in cardiovascular disease and aging |
| Q40628307 | Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice11See Editorial by Kasinath, p. 1918 |
| Q36370888 | Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). |
| Q33676724 | Effects of nonsteroidal anti-inflammatory therapy on platelets |
| Q87985046 | Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond) |
| Q93345082 | Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies |
| Q37142660 | Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins |
| Q38272869 | Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling. |
| Q38642400 | First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis |
| Q47358955 | Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions |
| Q48832499 | Genetic ablation and short-duration inhibition of lipoxygenase results in increased macroautophagy |
| Q35330471 | Group VIB calcium-independent phospholipase A2 (iPLA2γ) regulates platelet activation, hemostasis and thrombosis in mice |
| Q28586401 | Increased thrombin responsiveness in platelets from mice lacking glycoprotein V |
| Q33791854 | Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions |
| Q37416809 | Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis |
| Q39021950 | Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again? |
| Q34997977 | Lipoxygenase genes and their targeted disruption |
| Q28709175 | Lipoxygenase pathways in Homo neanderthalensis: functional comparison with Homo sapiens isoforms |
| Q28249730 | Mammalian lipoxygenases and their biological relevance |
| Q46252434 | Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis. |
| Q39147112 | New Concepts and Mechanisms of Platelet Activation Signaling |
| Q33416935 | Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation |
| Q35213593 | Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection |
| Q26998976 | Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets |
| Q35845952 | Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA |
| Q33375459 | Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase |
| Q34560219 | Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis |
| Q33388380 | RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency |
| Q31808197 | Role of 'platelet-type' 12-lipoxygenase in skin carcinogenesis |
| Q28349952 | Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse |
| Q50336029 | Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation |
| Q35651297 | Targeted knock-down of a structurally atypical zebrafish 12S-lipoxygenase leads to severe impairment of embryonic development |
| Q26823893 | The emerging role of oxylipins in thrombosis and diabetes |
| Q39320449 | The expansive role of oxylipins on platelet biology. |
| Q26795652 | The role of lipoxygenases in pathophysiology; new insights and future perspectives |
| Q33330294 | Transforming growth factor beta1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor |
| Q47983293 | cDNA cloning of 15-lipoxygenase type 2 and 12-lipoxygenases of bovine corneal epithelium |
Search more.